Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.

Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ.

Immunity. 2008 Jul 18;29(1):114-26. doi: 10.1016/j.immuni.2008.05.010.

2.

Unique maturation program of the IgE response in vivo.

Erazo A, Kutchukhidze N, Leung M, Christ AP, Urban JF Jr, Curotto de Lafaille MA, Lafaille JJ.

Immunity. 2007 Feb;26(2):191-203. Epub 2007 Feb 8.

3.

Oral tolerance in the absence of naturally occurring Tregs.

Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA.

J Clin Invest. 2005 Jul;115(7):1923-33. Epub 2005 Jun 2.

4.

CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.

Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ.

J Immunol. 2004 Dec 15;173(12):7259-68.

5.

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ.

J Exp Med. 2002 Sep 16;196(6):851-7.

6.

Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes.

Curotto de Lafaille MA, Muriglan S, Sunshine MJ, Lei Y, Kutchukhidze N, Furtado GC, Wensky AK, Olivares-Villagómez D, Lafaille JJ.

J Exp Med. 2001 Nov 5;194(9):1349-59.

7.
8.
9.

Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.

Carr KD, Kutchukhidze N, Park TH.

Brain Res. 1999 Mar 20;822(1-2):34-42.

PMID:
10082881

Supplemental Content

Loading ...
Support Center